Drugs for Gonadal Dysgenesis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 29)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Î’)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Î’ oestradiol
17Î’-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Î’-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Î’-estradiol
|
|
2 |
|
Polyestradiol phosphate |
Approved |
Phase 4 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
3 |
|
Progesterone |
Approved, Vet_approved |
Phase 4 |
|
57-83-0 |
5994 |
Synonyms:
(1S,2R,10S,11S,14S,15S)-14-ACETYL-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
(8S,9S,10R,13S,14S,17S)-17-ACETYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9S,10R,13S,14S,17S)-17-ETHANOYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(S)-4-PREGNENE-3,20-DIONE
(S)-PREGN-4-EN-3,20-DIONE
(S)-PROGESTERONE
17ALPHA-PROGESTERONE
17A-PROGESTERONE
17Α-PROGESTERONE
3,20-PREGNENE-4
4-PREGNEN-3,20-DIONE
4-PREGNENE-3,20-DIONE
AGOLUTIN
AKROLUTIN
Amen
BETA-PROGESTERONE
BIO-LUTON
CIDR
COLPROSTERONE
CORLUTIN
CORLUTINA
CORLUVITE
CORPORIN
CORPUS LUTEUM HORMONE
CRINONE
CRINONE PROGESTERONE GEL
CURRETAB
CYCLOGEST
CYCLOGESTERIN
Cycrin
D4-PREGNENE-3,20-DIONE
DELALUTIN
DELTA(4)-PREGNENE-3,20-DIONE
DELTA(SUP 4)-PREGNENE-3,20-DIONE
DURAPROGEN
ENDOMETRIN
ESTIMA
FLAVOLUTAN
FOLOGENON
Gelbkoerperhormon
GELBKÖRPERHORMON
GESTEROL
GESTEROL 100
GESTEROL 50
GESTIRON
GESTONE
GESTORMONE
GESTRON
GLANDUCORPIN
GYNLUTIN
GYNOLUTON
GYNOLUTONE
HORMOFLAVEINE
HORMOLUTON
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
LINGUSORBS
LIPO-LUTIN
LUCORTEUM
LUCORTEUM SOL
LUGESTERON
LUTEAL HORMONE
Luteinique
LUTEOCRIN NORMALE
LUTEODYN
LUTEOGAN
LUTEOHORMONE
LUTEOL
LUTEOPUR
LUTEOSAN
LUTEOSTAB
LUTEOVIS
LUTEUM
LUTEX
LUTIDON
LUTIGEST
|
Lutin
LUTOCICLINA
LUTOCUCLIN M
LUTOCYCLIN
LUTOCYCLIN M
LUTOCYLIN
LUTOCYLOL
LUTOFORM
LUTOGYL
LUTOGYNON
LUTREN
LUTROMONE
MEMBRETTES
METHYLPREGNONE
MPA
NALUTRON
NSC-64377
NSC-9704
PERCUTACRINE
PERCUTACRINE LUTEINIQUE
PIAPONON
PRANONE
PREGN-4-EN-3,20-DIONE
PREGN-4-ENE-3,20-DIONE
PREGNENE-3,20-DIONE
PREGNENEDIONE
PRIMOLUT
PROCHIEVE
PROGEFFIK
PROGEKAN
PROGESTA-CARE
PROGESTAN
PROGESTASERT
PROGESTEROL
PROGESTERON
PROGESTERONA
Progesterona [INN-Spanish]
PROGESTERONE
PROGESTÉRONE
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
PROGESTERONUM
Progesteronum [INN-Latin]
PROGESTIN
PROGESTOGEL
PROGESTOL
PROGESTON
PROGESTONE
PROGESTOSOL
PROGESTRON
PROGESTRONOL
PROJESTAJECT
PROLETS
PROLIDON
PROLUTIN
PROLUTON
PROLUTONE
PROMETRIUM
Prometrium®|Utrogestan®
PRONTOGEST
PROTORMONE
REGUMATE
SERENITY FOR WOMEN
SYNGESTERONE
SYNGESTRETS
SYNGESTRONE
SYNOVEX S
SYNTOLUTAN
Thiuram E
Thiuranide
U 3672
UTROGEST
UTROGESTAN
VITARRINE
Δ(4)-pregnene-3,20-dione
|
|
4 |
|
Estrogens |
|
Phase 4 |
|
|
|
5 |
|
Estradiol 3-benzoate |
|
Phase 4 |
|
|
|
6 |
|
Estradiol 17 beta-cypionate |
|
Phase 4 |
|
|
|
7 |
|
Hormones |
|
Phase 4 |
|
|
|
8 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
9 |
|
Ethinylestradiol |
Approved |
Phase 3 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
10 |
|
Oxandrolone |
Approved, Investigational |
Phase 3 |
|
53-39-4 |
5878 |
Synonyms:
Anavar
NSC-67068
Ossandrolone
Oxandrin
Oxandrolon
Oxandrolona
|
Oxandrolone
OXANDROLONE CIII
Oxandrolonum
PROTIVAR
SC-11585
|
|
11 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 3 |
|
520-85-4, 71-58-9 |
6279 10631 |
Synonyms:
(6ALPHA)-17-(ACETYLOXY)-6-METHYLPREG-4-ENE-3,20-DIONE
(6α)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha methylprogesterone
17 alpha-Hydroxy-6 alpha-methylprogesterone
17-ACETOXY-6ALPHA-METHYLPROGESTERONE
17-ACETOXY-6Α-METHYLPROGESTERONE
17a-Hydroxy-6a-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone
17ALPHA-HYDROXY-6ALPHA-METHYLPROGESTERONE ACETATE
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17-Hydroxy-6a-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6α-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6α-methylprogesterone
17Α-hydroxy-6α-methylprogesterone
17Α-HYDROXY-6Α-METHYLPROGESTERONE ACETATE
6ALPHA-METHYL-17-ACETOXY PROGESTERONE
6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE
6alpha-Methyl-17alpha-hydroxyprogesterone
6ALPHA-METHYL-17ALPHA-HYDROXYPROGESTERONE ACETATE
6-ALPHA-METHYL-17-ALPHA-HYDROXYPROGESTERONE ACETATE
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6ALPHA-METHYL-4-PREGNENE-3,20-DION-17ALPHA-OL ACETATE
6a-Methyl-17a-hydroxyprogesterone
6a-Methyl-4-pregnen-17a-ol-3,20-dione
6Α-METHYL-17-ACETOXY PROGESTERONE
6Α-methyl-17α-hydroxyprogesterone
6Α-METHYL-17Α-HYDROXYPROGESTERONE ACETATE
6Α-methyl-4-pregnen-17α-ol-3,20-dione
6α-Methyl-4-pregnene-3,20-dion-17α-ol acetate
ADGYN MEDRO
AMEN
Aragest
Aragest 5
Asconale
CBP-1011
CLIMANOR
Clinofem
Clinovir
Colirest
CURRETAB
CYCRIN
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
DEPO-PROGEVERA
Depo-Promone
DEPO-PROVERA
DEPO-PROVERA ONCOLOGY
DEPO-SUBQ PROVERA 104
Depot-Medroxyprogesterone acetate
DMPA
FARLUTAL
FARLUTAL 100
FARLUTAL 200
FARLUTAL 250
FARLUTAL 500
Farlutal inyectable
|
Farlutin
Gestapuran
G-Farlutal
Hematrol
Hydroxymethylprogesterone
hydroxymethylprogesterone|MPA
Hysron
Indivina
LUNELLE
Lutopolar
Lutoral
MAP
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [Dcit]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
MEDROXIPROGESTERONE ACETATE
Medroxiprogesteronum
MEDROXYACETATE PROGESTERONE
Medroxyprogesteron
Medroxyprogesteron acetate
MEDROXYPROGESTERONE
MEDROXYPROGESTERONE 17-ACETATE
MEDROXYPROGESTERONE ACETATE
Medroxyprogesterone strakan brand
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
METHYLACETOXYPROGESTERONE
Methylhydroxyprogesterone
METIGESTRONA
MPA
MPA Gyn 5
Nadigest
Nidaxin
Novo-Medrone
NSC-21171
NSC-26386
Oragest
Perlutex
Perlutex Leo
PREMPRO
Prodasone
Progestalfa
Progevera
PROVERA
Proverone
Ralovera
Repromap
Repromix
SAYANA PRESS
Sirprogen
Sodelut G
Strakan brand OF medroxyprogesterone
TV-46046
Veramix
|
|
12 |
|
Contraceptive Agents |
|
Phase 3 |
|
|
|
13 |
|
Antineoplastic Agents, Hormonal |
|
Phase 3 |
|
|
|
14 |
|
Contraceptives, Oral, Hormonal |
|
Phase 3 |
|
|
|
15 |
|
Contraceptives, Oral |
|
Phase 3 |
|
|
|
16 |
|
Contraceptive Agents, Male |
|
Phase 3 |
|
|
|
17 |
|
Anabolic Agents |
|
Phase 2 |
|
|
|
18 |
|
Norethisterone |
Approved |
|
|
68-22-4 |
199472 6230 |
Synonyms:
(-)-Gallocatechin gallic acid
(-)-Gallocatechin-3-O-gallate
(-)-Gallocatechin-3-O-gallic acid
(-)-Gallocatechol gallate
(-)-Gallocatechol gallic acid
(17a)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17Α)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoic acid)
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid
17a-Ethinyl-19-nortestosterone
17a-Ethinylestra-4-en-17b-ol-3-one
17a-Ethynyl-17b-hydroxy-19-norandrost-4-en-3-one
17a-Ethynyl-17-hydroxy-4-estren-3-one
17-a-Ethynyl-17-hydroxy-4-estren-3-one
17a-Ethynyl-19-nor-4-androsten-17b-ol-3-one
17a-Ethynyl-19-norandrost-4-en-17b-ol-3-one
17-a-Ethynyl-19-norandrost-4-en-17-b-ol-3-one
17a-Ethynyl-19-nortestosterone
17-a-Ethynyl-19-nortestosterone
17a-Ethynyl-4-estren-17-ol-3-one
17-a-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-ethinyl-19-nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17-hydroxy-estr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17-alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-Pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (acd/name 4.0)
17-Ethynyl-19-nortestosterone
17-Hydroxy-(17alpha)-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one
17Α-ethinyl-19-nortestosterone
17Α-ethinylestra-4-en-17β-ol-3-one
17Α-ethynyl-17-hydroxy-4-estren-3-one
17-Α-ethynyl-17-hydroxy-4-estren-3-one
17Α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one
17Α-ethynyl-19-nor-4-androsten-17β-ol-3-one
17Α-ethynyl-19-norandrost-4-en-17β-ol-3-one
17-Α-ethynyl-19-norandrost-4-en-17-β-ol-3-one
17Α-ethynyl-19-nortestosterone
17-Α-ethynyl-19-nortestosterone
17Α-ethynyl-4-estren-17-ol-3-one
17-Α-ethynyl-4-estren-17-ol-3-one
17Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
17-Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17a-ethynyl-17b-hydroxy-4-androsten-3-one
19-Nor-17-a-ethynyl-17-b-hydroxy-4-androsten-3-one
19-Nor-17a-ethynylandrosten-17b-ol-3-one
19-Nor-17-a-ethynylandrosten-17-b-ol-3-one
19-Nor-17a-ethynyltestosterone
19-Nor-17-a-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
|
19-Nor-17alpha-ethynyltestosterone
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyltestosterone
19-Nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one
19-Nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one
19-Nor-17α-ethynylandrosten-17β-ol-3-one
19-Nor-17-α-ethynylandrosten-17-β-ol-3-one
19-Nor-17α-ethynyltestosterone
19-Nor-17-α-ethynyltestosterone
19-Nor-ethindrone
19-Norethinyltestosterone
19-Norethisterone
4-Estren-17a-ethynyl-17b-ol-3-one
4-Estren-17alpha-ethynyl-17beta-ol-3-one
4-Estren-17α-ethynyl-17β-ol-3-one
ACTIVELLA
Anhydrohydroxynorprogesterone
Anovule
AYGESTIN
Camila
COMBIPATCH
Conceplan
Conludaf
Conludag
ENT
ent-Gallocatechin 3-gallic acid
ERRIN
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylnortestosterone
FEMHRT
Gallocatechin gallate
Gallocatechin-3-gallate
Gestest
HEATHER
INCASSIA
JENCYCLA
Menzol
Micronett
Micronor
MICRONOR HRT
Micronor®|norethindrone|Noriday®
Micronovum
Mini-pe
Mini-pill
Minovlar
Monogest
NEA713
NET
Nor QD
Noralutin
Norcolut
Norcolute
Noresthisterone
NORETHIDRONE
Norethindrone
Norethindrone, (1 beta)-isomer
Norethisteron
Norethisterone
Noréthistérone
Norethisteronum
Norethyndron
Norethynodrone
Noretisterona
Norfor
Norgestin
Noriday
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Nor-q.d.
NorQD
Nor-QD
NSC-9564
Primolut N
Primolut-N
Proluteasi
SC-4640
Utovlan
Utovlar
|
|
19 |
|
Racepinephrine |
Approved, Vet_approved |
|
|
51-43-4, 329-65-7 |
838 5816 |
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]BENZYL ALCOHOL(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]-BENZYL ALCOHOL
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenaline
(−)-ADRENALINE
(-)-Epinephrine
(+-)-Adrenaline
(+-)-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(−)-ADRENALINE
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
2-(Methylamino)-1-(3,4-dihydroxyphenyl)ethanol
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-HYDROXY-2-METHYLAMINOETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]PYROCATECHOL
Acetate, epinephrine
Adnephrine
ADREN CO
ADRENACLICK
Adrenal
Adrenalin
adrenalin|Auvi-Q®|Epipen®|l-adrenaline|L-epinephrine|levoepinephrine
Adrenaline
Adrénaline
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
adrenaline|epinephrine
Adrenine
Adrin
Allergan brand OF adrenaline hydrochloride
ANA-GUARD
Ana-kit
ANAPEN
ANAPHYLACTIC SHOCK DRUG KIT
ASMA-VYDRIN
ASTHMAHALER
Auvi-Q
Bird brand OF racepinefrine hydrochloride
Bosmin
Bronkaid mist
BROVON
Chelafrin
DL-Adrenaline
EMERADE
EPI E Z PEN JR
Epifrin
Epiglaufrin
Epinefrin
Epinefrina
Epinephran
Epinephrin
EPINEPHRINE
Epinephrine acetate
Epinephrine bitartrate
EPINEPHRINE HCL
Epinephrine hydrochloride
Epinephrine hydrochloride, racemic mixture
Epinephrine hydrogen tartrate
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Epinephrinum
Epipen
|
EPIPEN E Z PEN
Epipen JR
EPIPEN JR.
Epirenan
Epitrate
Eppy
Exadrin
Glauposine
GPPE INH SOLN
Hemisine
Hemostasin
Hemostatin
Hydrochloride, racepinephrine
Hypernephrin
Isoptoepinal
JEXT
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-DETHYLAMINOETHANOLCATECHOL
L-Epinephrine
L-Epirenamine
Levoepinephrine
LEVO-METHYLAMINOETHANOLCATECHOL
Levorenen
Levorenin
Levorenine
Levoreninum
L-Methylaminoethanolcatechol
Lyodrin
Lyophrin
Medihaler-epi
Methylarterenol
Micronefrin
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Mucidrina
Nephridine
Nieraline
NSC-62786
Paranephrin
Primatene
Primatene mist
R-(-)-Epinephrine
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Renaglandin
Renaleptine
Renalina
Renoform
Renostypticin
Renostyptin
RIDDOBRON
RIDDOFAN
RYBARVIN
Scurenaline
Simplene
SOLN MADE TO RYBARVIN FOR
Styptirenal
Supracapsulin
Supranephrane
Suprarenaline
Suprarenin
Surrenine
Sus-phrine
SUS-PHRINE SULFITE FREE
SUS-PHRINE SULFITE-FREE
SYMJEPI
Takamina
TWINJECT
TWINJECT 0.15
TWINJECT 0.3
Vaponefrin
Vasoconstrictine
Vasotonin
|
|
20 |
|
Prasterone |
Approved, Investigational, Nutraceutical |
|
|
53-43-0 |
5881 |
Synonyms:
(+)-Dehydroisoandrosterone
(3beta)-3-Hydroxy-androst-5-en-17-one
(3-beta)-3-Hydroxyandrost-5-en-17-one
(3beta,16alpha)-3,16-Dihydroxy-androst-5-en-17-one
17-Chetovis
17-Hormoforin
3beta-Hydroxy-5-androsten-17-one
3-BETA-HYDROXY-5-androsten-17-one
3beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-androst-5-en-17-one
3-beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-D5-androsten-17-one
3-b-HYDROXY-5-androsten-17-one
3b-Hydroxyandrost-5-en-17-one
3b-Hydroxy-D5-androsten-17-one
3-Î’-hydroxy-5-androsten-17-one
3Î’-hydroxyandrost-5-en-17-one
5 Androsten 3 beta hydroxy 17 one
5 Androsten 3 ol 17 one
5,6-Dehydroisoandrosterone
5,6-Didehydroisoandrosterone
5-Androsten-3-beta-hydroxy-17-one
5-Androsten-3beta-ol-17-one
5-Androsten-3-beta-ol-17-one
5-Androsten-3b-ol-17-one
5-Androsten-3-ol-17-one
5-Dehydroepiandrosterone
5-Dehydro-epiandrosterone
Andrestenol
Androst-5-ene-3beta-ol-17-one
Androst-5-ene-3b-ol-17-one
|
Androsten-3beta-ol-17-one
Androstenolone
Astenile
Biolaif
D5-Androsten-3beta-ol-17-one
D5-Androsten-3b-ol-17-one
Deandros
DEHYDROANDROSTERONE
Dehydro-epi-androsterone
DEHYDROEPIANDROSTERONE
Dehydroisoandrosterone
DHA
DHEA
Diandron
Diandrone
EM-760
EM-760Dehydroandrosterone
ENZYMATIC THERAPY
Hydroxyandrostenone
Intrarosa
NATROL DHEA
NSC-9896
Prasterona
Prasterone
Prasterone, 3 alpha isomer
Prasterone, 3 alpha-isomer
Prasteronum
Prestara
Psicosterone
trans-Dehydroandrosterone
|
|
21 |
|
Trisequens |
|
|
|
|
|
22 |
|
Norethindrone Acetate |
|
|
|
|
541197 |
Synonyms:
14-Ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl acetic acid
Aygestin
NORETHIDRONE ACETATE
NORETHINDRONE ACETATE
Norethindrone acetate, (17alpha)-(+-)-isomer
Norethindrone acetate, (17alpha)-isomer
|
Norethindrone acetic acid
Norethisterone acetate
Norlutate
NSC-22844
SH-420
|
|
23 |
|
Liver Extracts |
|
|
|
|
|
24 |
|
Androgens |
|
|
|
|
|
25 |
|
Epinephryl borate |
|
|
|
|
|
26 |
|
Follicle Stimulating Hormone |
|
|
|
|
|
27 |
|
DHEA (Dehydroepiandrosterone) |
|
|
|
|
|
28 |
|
Insulin, Globin Zinc |
|
|
|
|
|
29 |
|
Insulin |
|
|
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
Interventional clinical trials:
(show top 50)
(show all 90)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism |
Completed |
NCT00837616 |
Phase 4 |
17 B estradiol orally;17 B estradiol |
2 |
A Multi-center, Open, Single-arm, Switch-over, Prospective, Phase IV Study to Assess the Ease of Use, Preference, and Safety After 8 Weeks Subcutaneous Administration of EutropinPen Inj. in Patients Pretreated With Recombinant Human Growth Hormone by Reusable Device |
Completed |
NCT03015909 |
Phase 4 |
Somatropin |
3 |
Collaborative Study to Assess the Effects of Treatment With Recombinant Growth Hormone Saizen® in the Prevention of Short Stature in Young Girls Suffering From Turner Syndrome Before the Age of 4 Years. Original French Title: Etude Collaborative Pour apprécier Les Effets du Traitement Par l'Hormone de Croissance Recombinante SAIZEN® Dans le Retard de Croissance de la Fillette Atteinte de Syndrome de Turner Avant l'âge de 4 Ans |
Completed |
NCT01066052 |
Phase 4 |
r-hGH |
4 |
The Growth of Genitalia Interna and the Bone Mineralization Under Hormonal Replacement Therapy and the Presence of Aortic Root Dilatation in Girls With Turner Syndrome |
Completed |
NCT00134745 |
Phase 4 |
estradiol |
5 |
Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome |
Completed |
NCT00266656 |
Phase 4 |
Humatrope |
6 |
A Phase IV Open-label Study of Predictive Markers in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children Treated With SAIZEN® |
Completed |
NCT00256126 |
Phase 4 |
Saizen |
7 |
Dose Response Trial of Biosynthetic Authentic Human Growth Hormone and Induction of Puberty With 17b Oestradiol in Girls With Turner's Syndrome |
Completed |
NCT01518062 |
Phase 4 |
somatropin;oestrogen |
8 |
Growth Response in Girls With Turner Syndrome During a Three-year GH Treatment Comparing Two Dose Regimens. Identification of Predictive Factors of Growth Response |
Completed |
NCT01734486 |
Phase 4 |
somatropin |
9 |
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study |
Completed |
NCT01419249 |
Phase 4 |
|
10 |
Assessment of the Ease of Use of Norditropin NordiFlex® Relative to the One of the Device Previously Used by Patients or Parents |
Completed |
NCT01245374 |
Phase 4 |
|
11 |
The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome |
Completed |
NCT00406926 |
Phase 3 |
Somatropin |
12 |
Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery |
Completed |
NCT00140998 |
Phase 3 |
17 beta estradiol |
13 |
Humatrope Treatment to Final Height in Turner's Syndrome |
Completed |
NCT00191113 |
Phase 3 |
Somatropin;Ethinyl estradiol;Medroxyprogesterone acetate |
14 |
The Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate and Cognitive Function of Growth Hormone-treated Girls With Turner Syndrome |
Completed |
NCT00029159 |
Phase 3 |
estrogen;androgen |
15 |
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG (Recombinant Somatropin) Administered by ZomaJet Vision X |
Completed |
NCT00250250 |
Phase 3 |
ZOMACTON |
16 |
Phase IIIB, International, Single Group, Open Study to Define an Optimal Monitoring of IGF-1 in Children Treated With NutropinAq, Using a Novel Capillary Blood Collection Method |
Completed |
NCT00234533 |
Phase 3 |
Somatropin (rDNA origin) |
17 |
The Use of Norditropin® in Turner's Syndrome |
Completed |
NCT01518036 |
Phase 3 |
somatropin |
18 |
An Open, Multi-Centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin Simplexxâ„¢ in Children With GH Deficiency |
Completed |
NCT01563926 |
Phase 3 |
somatropin |
19 |
Induction of Puberty With 17-Beta Estradiol in Girls With Turner Syndrome. An Open Randomized Trial |
Completed |
NCT01710696 |
Phase 3 |
17-beta estradiol |
20 |
Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Patients With Turner's Syndrome |
Completed |
NCT01813630 |
Phase 3 |
DA-3002;Genotropin® |
21 |
A Study Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® as Well as Evaluating Long-term Safety of Somapacitan in a Basket Study Design in Children With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature |
Recruiting |
NCT05330325 |
Phase 3 |
Somapacitan;Norditropin® |
22 |
A Phase 2 Study of Pegylated Recombinant Human Growth Hormone Injection to Treat Children of Turner Syndrome |
Unknown status |
NCT03189160 |
Phase 2 |
|
23 |
A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome |
Completed |
NCT00001221 |
Phase 2 |
Growth Hormone (Humatrope) |
24 |
Estrogen Effects on Cognition in Girls With Turner Syndrome |
Completed |
NCT00001253 |
Phase 2 |
|
25 |
Turner Syndrome: Hormone Replacement Therapy |
Completed |
NCT00013546 |
Phase 2 |
TMTDS |
26 |
Phase II Randomized Study of Oxandrolone vs Placebo for Growth Hormone-Treated Girls With Turner's Syndrome |
Completed |
NCT00004275 |
Phase 2 |
growth hormone;oxandrolone |
27 |
The Relative Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate, GH Binding Protein, IGF-I, and Cognitive Function in Growth Hormone-Treated Girls With Turner Syndrome |
Completed |
NCT00001343 |
Phase 2 |
Humatrope;Oxandrolone |
28 |
Initiating Transdermal Estradiol Therapy in Turner's Syndrome |
Terminated |
NCT00870220 |
Phase 1 |
Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch |
29 |
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome |
Unknown status |
NCT03812913 |
|
|
30 |
Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection. |
Unknown status |
NCT01678274 |
|
|
31 |
National Collaborative Study of Girls Prenatally Diagnosed With Turner Syndrome Karyotypes |
Unknown status |
NCT01668251 |
|
|
32 |
The Risk of Venous Thrombosis in Women With Turner Syndrome |
Unknown status |
NCT00594763 |
|
|
33 |
Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome |
Unknown status |
NCT00625001 |
|
|
34 |
Aortic Dimensions, 24hour Ambulatory Blood Pressure and Sympathovagal Tone in Turner Syndrome. In Relation to Aortic Dilatation and Dissection. |
Unknown status |
NCT00624949 |
|
|
35 |
Whole Blood Specimen Collection From Pregnant Subjects |
Unknown status |
NCT02430584 |
|
|
36 |
Variability of Uterine and Breast Development in Response to Exogenous Oestrogen During Induction of Puberty in Individuals With Hypogonadism. |
Unknown status |
NCT02871986 |
|
Routine transdermal oestrogen patch |
37 |
Observational Long-term Follow-up of the Phase IV Open-label Trial of Predictive Markers in GHD and TS Pre-pubertal Children Treated With Saizen |
Completed |
NCT00699855 |
|
|
38 |
Social Cognition and Turner Syndrome |
Completed |
NCT01687842 |
|
|
39 |
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome |
Completed |
NCT00471731 |
|
|
40 |
Evaluation of Convenience and Compliance of the Easypodâ„¢ Electronic Self-injector When Administering Saizen® Growth Hormone to Children With Growth Disorders |
Completed |
NCT00738205 |
|
|
41 |
Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy |
Completed |
NCT00825617 |
|
Hormone replacement therapy |
42 |
D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome |
Completed |
NCT00443144 |
|
recombinant human growth hormone |
43 |
Growth Hormone Treatment of Women With Turner Syndrome: Body Composition and Heart Function. |
Completed |
NCT00420654 |
|
Growth Hormone;Placebo |
44 |
X-chromosome Inactivation, Epigenetics and the Transcriptome |
Completed |
NCT01678261 |
|
|
45 |
A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs. |
Completed |
NCT01604161 |
|
somatropin |
46 |
Sex Differences in Early Brain Development; Brain Development in Turner Syndrome |
Completed |
NCT00877942 |
|
|
47 |
Controlled Study of Estrogen Effects on Cognitive and Social Function in Girls With Turner's Syndrome |
Completed |
NCT00004274 |
|
Estrogen |
48 |
Pilot Study of Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome |
Completed |
NCT03181230 |
|
|
49 |
Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS) |
Completed |
NCT00097552 |
|
|
50 |
Bone Mineral Density in Adolescent Subjects With Growth Hormone Deficiency Who Are Completing Treatment With Nutropin AQ, Nutropin, or Protropin in the National Cooperative Growth Study (NCGS) |
Completed |
NCT00097526 |
|
|
|